Self Containing Enclosure for Protection from Killer Bees
A self contained protective enclosure with an opening for entry and egress and a screen for ventilation and viewing.
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 8022050 | Compound for inhibiting TRPA1 function and use thereof The present invention relates to a TRPA1 activation inhibitor, more precisely a TRPA1 activity inhibitor containing isopentenyl pyrophosphate and a method for inhibiting pain containing the step of administering isopentenyl pyrophosphate to a subject. Isopentenyl py... | 09/20/2011 |
| 7309698 | Compositions for delivering bisphosphonates Compounds and compositions for the delivery of bisphosphonates are provided. Methods of preparation, administration and treatment are provided as well. ... | 12/18/2007 |
| 7192940 | Ether compounds The present invention relates to novel ether compounds, compositions comprising ether compounds, and methods useful for treating and preventing cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders comprising administering a compo... | 03/20/2007 |
| 7132441 | Immunosuppressive effects of administration of a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor This invention is in the field of a combination comprising a therapeutically-effective amount of a cyclooxygenase-2 inhibitor, a 5-lipoxygenase inhibitor and an immunosuppressive drug selected from antiproliferative agents, antiinflammatory-acting compounds and inhi... | 11/07/2006 |
| 7101711 | Phosphoepoxides, method for making same and uses The invention provides compounds comprising at least one phosphoepoxide group of the formula: where R1 is selected from among —CH3 and —CH2—CH3, ... | 09/05/2006 |
| 7084126 | Methods and compositions for enhancing cellular function through protection of tissue components Methods and composisions for enhancing cellular function through protection of a tissue components such receptors, proteins, lipids, nucleic acids, carbohydrates, hormones, vitamins, and cofactors, by administering pyrophosphate analogs or related compounds. ... | 08/01/2006 |
| 7078426 | Aryl substituted pyrazoles, triazoles, and tetrazoles, and the use thereof This invention relates to compounds having the Formula I: or a pharmaceutically acceptable salt, prodrug or solvate thereof, wherein Het and R5-R8 are set in the specification. The invention also ... | 07/18/2006 |
| 7074432 | Method of modifying the release profile of sustained release compositions The present invention relates to a method for the sustained release in vivo of a biologically active agent comprising administering to a subject in need of treatment an effective amount of a sustained release composition comprising a biocompatible polymer having the... | 07/11/2006 |
| 6919363 | Aryl substituted pyrazoles, triazoles and tetrazoles, and the use thereof This invention relates to compounds having the Formula I: or a pharmaceutically acceptable salt, prodrug or solvate thereof, wherein Het and R5-R8 are set in the specification. The invention also ... | 07/19/2005 |
| 6589564 | Use of magnesium based products for the treatment of neoplastic diseases A method of treating solid neoplastic diseases is disclosed, which involves administering to a host in need of such treatment an effective amount of a pharmaceutically acceptable magnesium salt or complex, which can be a pharmaceutically acceptable inorga... | 07/08/2003 |
| 6525035 | Therapeutic composition and methods The invention provides composition comprising, 1) polyprenol monophosphates of the formula H--[--CH2-C(CH3).dbd.CH--CH2]n-O--P(.dbd.O)(OH)2 wherein n is an integer from 6-19 inclusive or a salt thereof, and 2) polyprenol pyrophosphates of the formula H--[... | 02/25/2003 |
| 6476006 | Composition and dosage form for delayed gastric release of alendronate and/or other bis-phosphonates The present invention provides compacted pharmaceutical composition for oral administration to a patient which expands upon contact with gastric fluid to retain a dosage form in the patient's stomach for an extended period of time, the formulation compris... | 11/05/2002 |
| 6008205 | Polyisoprenyl phosphate stable analogs for regulation of neutrophil responses The present invention is directed to presqualene diphosphate (PSDP) analogs having an active region of natural PSDP and a metabolic transformation region resistant to rapid intracellular inactivation in vivo. For example, PSDP and its stable analogs can i... | 12/28/1999 |
| 5885973 | Bone mass anabolic composition comprising olpadronate The present invention provides methods for bone mass anabolic preservation or augmentation in human or other animal subjects affected by osteoporosis or other metabolic bone disorder characterized by systemic or regional bone loss, using bisphosphonates f... | 03/23/1999 |
| 5827838 | Method for the treatment of diseases related with protein isoprenylation The invention provides a method for inhibiting protein isoprenylation by administration of a polyisoprenyl pyrophosphate analogue. The polyisoprenyl pyrophosphate analogue may have formula 1, ##STR1## wherein: Pren represents a C10 -C... | 10/27/1998 |
| 5639653 | Method for proliferating Vγ2Vδ2 T cells This invention is directed to a method for stimulating the proliferation of Vγ2Vδ2 T cells comprising contacting Vγ2Vδ2 T cells with a Vγ2Vδ2 T cell proliferation stimulating amount of a compound selected from the group consisting of a monoalkyl pho... | 06/17/1997 |
| 5591730 | Inhibition of urinary calculi growth The present invention provides metal ion/bisphosphonate complexes that are useful for the treatment and diagnosis of urinary calculi. Preferred bisphosphonates include etidronate, pamidronate (APD), methylene diphosphonate (MDP), and imidodiphosphonate (I... | 01/07/1997 |
| 5474712 | Livestock conditioning shampoo A livestock conditioning shampoo consists of sodium lauryl sulfate, polyoxyethylene (20) sorbitan monolaurate, d-limonene, polyacrylic acid, acrylic copolymer emulsifier, butylated hydroxytoluene, triethanolamine, polyalkyleneoxide-modified polydimethylsi... | 12/12/1995 |
| 5393545 | Composition active against botulism This invention relates to a composition of food having animal and/or vegetable origin which contains lysozyme and a chelating agent in amounts that are effective at preventing contamination of the food by Clostridium botulinum.... | 02/28/1995 |
| 5380756 | Disinfecting shampoo composition for animals A shampoo composition and related process for disinfecting, cleansing, conditioning, and moisturizing the skin and coat of an animal. The composition involves the use of a fatty acid monoester of a polyhydroxy alcohol, such as monolaurin, as an antimicrob... | 01/10/1995 |
| 5378731 | Medicated shampoo A shampoo composition and related process for disinfecting, cleansing, conditioning, and moisturizing hair. The composition involves the use of a fatty acid monoester of a polyhydroxy alcohol, such as monolaurin, as an antimicrobial agent.... | 01/03/1995 |
| 5219887 | Disinfecting shampoo composition for animals A shampoo composition and related process for disinfecting, cleansing, conditioning, and moisturizing the skin and coat of an animal. The composition involves the use of a fatty acid monoester of a polyhydroxy alcohol, such as monolaurin, as an antimicrob... | 06/15/1993 |
| 5053222 | Hair cosmetic composition A hair cosmetic composition containing, as an active component, a diester of phosphoric acid with ascorbic acid and tocopherol, having the formula (I), and/or a salt thereof: ##STR1## wherein R1 represents H or CH3 and R2 | 10/01/1991 |
| 4994512 | Poly-methine compounds, condensation polymer having a poly-methine compound admixed therein and shaped articles produced therefrom Disclosed are poly-methine compounds having the formula: ##STR1## wherein R1 is an unsubstituted or substituted alkoxycarbonyl, cycloalkoxycarbonyl or aryloxycarbonyl radical; an unsubstituted or substituted carbamoyl radical; or an unsubs... | 02/19/1991 |
| 4613593 | Therapeutic and preventive agent containing dolichol Dolichol or phosphate thereof is useful as a therapeutically treating and preventive agent, in particular, for hyperuricuria, hyperlipemia, diabetes and hepatic diseases.... | 09/23/1986 |
| 4603126 | Therapeutic and preventive agent containing dolichol Dolichol or phosphate thereof is useful as a therapeutically treating and preventive agent, in particular, for hyperuricuria, hyperlipemia, diabetes and hepatic diseases.... | 07/29/1986 |
| 4599328 | Therapeutic and preventive agent containing dolichol Dolichol or phosphate thereof is useful as a therapeutically treating and preventive agent, in particular, for hyperuricuria, hyperlipemia, diabetes and hepatic diseases.... | 07/08/1986 |
| 4421750 | Organophosphoric acid ester anhydrides as pesticides New organophosphoric acid ester anhydride derivatives, more particularly new thiopyrophosphoric acid P,P,P'-trialkylester-P'-dialkylamide of the formula ##STR1## wherein R1 is an alkyl group of 3 to 6 carbon atoms and R2, R... | 12/20/1983 |
| 4291027 | Method for treating tumors with ethylenediamine platinum (II) and 1,2-diaminocyclohexane-platinum (II) pyrophosphate complexes Ethylenediamine platinum (II) and 1,2-diaminocyclohexane platinum (II) pyrophosphate complexes are prepared by reaction of the appropriate diaquo platinum (II) salt with a pyrophosphate salt. These complexes possess pronounced anti-tumor activity and low ... | 09/22/1981 |
| 4110440 | Pesticidal organophosphoric acid ester anhydrides Organophosphoric acid ester anhydrides of the formula ##STR1## in which R1 is alkyl with 1-6 carbon atoms, and R2 is alkoxy, alkylthio, alkylamino or dialkylamino Which possess arthropodicidal and nematicidal properties.... | 08/29/1978 |